Back to Markets
MEMesoblast Ltd

Mesoblast Ltd

MESOASX - ALL MARKETS
Health CareBiotechnology

$15.40

+0.6400 (+4.34%)

As of 05/29/26 EDT · USD

Compare
Low: $9.88Current: $15.40High: $21.50

Key Statistics

Open

$15.08

Day High

$15.55

Day Low

$15.08

Prev. Close

$14.76

VolumeShares traded today.

130.82K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$1.99B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-16.86

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$21.50

52W LowLowest price over the past 52 weeks.

$9.88

50D MAAverage closing price over the last 50 trading days.

$15.08

200D MAAverage closing price over the last 200 trading days.

$16.31

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+2.8%

1M

-1.0%

6M

-4.1%

YTD

-15.2%

1Y

+44.7%

About

Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

www.mesoblast.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeASX - ALL MARKETS
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade MESO

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.